In this regard, innovative RNAi nanoparticle-mediated Rictor knockdown has demonstrated specific mTORC2 inhibition in a preclinical breast cancer model, with a successful reduction in crucial cancer features [81]. This evidence concerns the gene RICTOR and breast cancer.